Trial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate Cancer
Clinical trial NCT02514213 · COMPLETED
Trial details
- NCT number
- NCT02514213
- Sponsor
- Inovio Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2017-12-12
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.